Demant A/S Total Assets
Demant A/S total assets. Based on the latest financial reports, Demant A/S (DEMANT) holds total assets worth Dkr39.07 Billion DKK (≈ $6.11 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see DEMANT cash flow metrics for how efficiently the company converts equity into cash flow.
Total Assets of Demant A/S (2002–2025)
Total assets of Demant A/S from 2002 to 2025. This chart illustrates how Demant A/S's total assets have evolved over time, based on quarterly financial data. See DEMANT live share price for real-time trading data and today's change.
Demant A/S - Asset Composition Analysis
Demant A/S Total Assets Breakdown (December 2025)
Demant A/S total assets breakdown as of December 2025. Demant A/S's total assets of Dkr39.07 Billion consist of 25.3% current assets and 74.7% non-current assets. Explore Demant A/S (DEMANT) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (DKK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 3.4% |
| Accounts Receivable | Dkr4.66 Billion | 11.9% |
| Inventory | Dkr2.62 Billion | 6.7% |
| Property, Plant & Equipment | Dkr0.00 | 0.0% |
| Intangible Assets | Dkr1.34 Billion | 3.4% |
| Goodwill | Dkr19.03 Billion | 48.7% |
Asset Composition Trend (2002–2025)
This chart illustrates how Demant A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Demant A/S's current assets represent 25.3% of total assets in 2025, a decrease from 73.9% in 2002.
- Cash Position: Cash and equivalents constituted 3.4% of total assets in 2025, down from 5.9% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 51.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 48.7% of total assets.
Demant A/S Competitors by Total Assets
Key competitors of Demant A/S based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SIEMENS HEALTH ADR/050
F:SHL1
|
Germany | €44.27 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Wellell Inc
TW:4106
|
Taiwan | NT$3.18 Billion |
|
MODULIGHT OY EO 1
F:78W
|
Germany | €46.32 Million |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
|
Heramed Ltd
AU:HMD
|
Australia | AU$1.04 Million |
Demant A/S - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.33 | 1.63 | 0.91 |
| Quick Ratio | 0.98 | 1.22 | 0.64 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Dkr2.48 Billion | Dkr3.83 Billion | Dkr-687.00 Million |
Demant A/S - Advanced Valuation Insights
This section examines the relationship between Demant A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.78 |
| Latest Market Cap to Assets Ratio | 0.31 |
| Asset Growth Rate (YoY) | 20.4% |
| Total Assets | Dkr39.07 Billion |
| Market Capitalization | $12.08 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Demant A/S's assets below their book value (0.31x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Demant A/S's assets grew by 20.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Demant A/S (2002–2025)
The table below shows the annual total assets of Demant A/S from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Dkr39.07 Billion ≈ $6.11 Billion |
+20.41% |
| 2024-12-31 | Dkr32.45 Billion ≈ $5.08 Billion |
+6.23% |
| 2023-12-31 | Dkr30.55 Billion ≈ $4.78 Billion |
+2.31% |
| 2022-12-31 | Dkr29.86 Billion ≈ $4.67 Billion |
+20.10% |
| 2021-12-31 | Dkr24.86 Billion ≈ $3.89 Billion |
+13.38% |
| 2020-12-31 | Dkr21.93 Billion ≈ $3.43 Billion |
+0.59% |
| 2019-12-31 | Dkr21.80 Billion ≈ $3.41 Billion |
+21.54% |
| 2018-12-31 | Dkr17.93 Billion ≈ $2.81 Billion |
+10.56% |
| 2017-12-31 | Dkr16.22 Billion ≈ $2.54 Billion |
+4.33% |
| 2016-12-31 | Dkr15.55 Billion ≈ $2.43 Billion |
+8.05% |
| 2015-12-31 | Dkr14.39 Billion ≈ $2.25 Billion |
+28.26% |
| 2014-12-31 | Dkr11.22 Billion ≈ $1.76 Billion |
+8.32% |
| 2013-12-31 | Dkr10.36 Billion ≈ $1.62 Billion |
+18.00% |
| 2012-12-31 | Dkr8.78 Billion ≈ $1.37 Billion |
+14.79% |
| 2011-12-31 | Dkr7.65 Billion ≈ $1.20 Billion |
+12.68% |
| 2010-12-31 | Dkr6.79 Billion ≈ $1.06 Billion |
+46.68% |
| 2009-12-31 | Dkr4.63 Billion ≈ $723.83 Million |
+17.83% |
| 2008-12-31 | Dkr3.93 Billion ≈ $614.30 Million |
+5.38% |
| 2007-12-31 | Dkr3.73 Billion ≈ $582.92 Million |
+18.86% |
| 2006-12-31 | Dkr3.13 Billion ≈ $490.42 Million |
+8.33% |
| 2005-12-31 | Dkr2.89 Billion ≈ $452.69 Million |
+18.54% |
| 2004-12-31 | Dkr2.44 Billion ≈ $381.90 Million |
+21.14% |
| 2003-12-31 | Dkr2.01 Billion ≈ $315.26 Million |
+1.18% |
| 2002-12-31 | Dkr1.99 Billion ≈ $311.59 Million |
-- |
About Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Hol… Read more